Biotech · Private company · San Diego, CA, US

Abterra Biosciences, Inc.

Track this companyFree. Adds Abterra Biosciences, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials0None registered

Pipeline programs0None found yet

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

NIH awards4

A platform for serum antibody repertoire analysis for autoimmune disease diagnosisFiscal year 2026 · $306.6KNIH RePORTER 1R43AI197772-01 · fetched Nov 12, 2026
REPTOR: accelerating antibody discovery and improving hits with machine learningFiscal year 2025 · $63.6KNIH RePORTER 3R44GM137688-02S1 · fetched Nov 12, 2026
REPTOR: accelerating antibody discovery and improving hits with machine learningFiscal year 2025 · $961.2KNIH RePORTER 5R44GM137688-03 · fetched Nov 12, 2026
REPTOR: accelerating antibody discovery and improving hits with machine learningFiscal year 2024 · $856.4KNIH RePORTER 2R44GM137688-02 · fetched Nov 12, 2026